These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 6489341)
21. Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159). Fears R; Dodd I; Ferres H; Robinson JH Biochem J; 1990 Mar; 266(3):693-6. PubMed ID: 2139324 [TBL] [Abstract][Full Text] [Related]
22. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase. Kouemo S; McMillan E; Doctor V Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443 [TBL] [Abstract][Full Text] [Related]
23. The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogen. Nieuwenhuizen W; Voskuilen M; Vermond A; Hoegee-de Nobel B; Traas DW Eur J Biochem; 1988 May; 174(1):163-9. PubMed ID: 3131143 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of the urokinase-catalyzed activation of human plasminogen. Violand BN; Castellino FJ J Biol Chem; 1976 Jul; 251(13):3906-12. PubMed ID: 132442 [TBL] [Abstract][Full Text] [Related]
25. Urokinase-catalysed plasminogen activation. Effects of ligands binding to the AH-site of plasminogen. Christensen U Biochim Biophys Acta; 1988 Nov; 957(2):258-65. PubMed ID: 3191143 [TBL] [Abstract][Full Text] [Related]
26. Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. Kinetic analysis of the initial phase of slow plasmin formation. Beckmann R; Geiger M; Binder BR J Biol Chem; 1988 May; 263(15):7176-80. PubMed ID: 2966802 [TBL] [Abstract][Full Text] [Related]
27. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator. Bell J; Duhon S; Doctor VM Blood Coagul Fibrinolysis; 2003 Apr; 14(3):229-34. PubMed ID: 12695744 [TBL] [Abstract][Full Text] [Related]
28. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators. Lind SE; Smith CJ Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651 [TBL] [Abstract][Full Text] [Related]
29. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase. Gao SW; Morser J; McLean K; Shuman MA Thromb Res; 1990 May; 58(4):421-33. PubMed ID: 2112791 [TBL] [Abstract][Full Text] [Related]
30. The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator. Lubin IM; Caban R; Runge MS J Biol Chem; 1993 Mar; 268(8):5550-6. PubMed ID: 8449917 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of fibrin binding and activation of plasminogen by staplabin through induction of a conformational change in plasminogen. Takayasu R; Hasumi K; Shinohara C; Endo A FEBS Lett; 1997 Nov; 418(1-2):58-62. PubMed ID: 9414095 [TBL] [Abstract][Full Text] [Related]
32. Species specificity in the acceleration of tissue-type plasminogen activator-mediated activation of plasminogens, by fibrinogen cyanogen bromide fragments. Nieuwenhuizen W; Keyser J Thromb Res; 1985 Jun; 38(6):663-70. PubMed ID: 4040660 [TBL] [Abstract][Full Text] [Related]
33. Plasminogen activation in diabetes mellitus. Kinetic analysis of plasmin formation using components isolated from the plasma of diabetic donors. Geiger M; Binder BR J Biol Chem; 1984 Mar; 259(5):2976-81. PubMed ID: 6230354 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of the activation of Glu-plasminogen by urokinase in the simultaneous presence of tranexamic acid or fibrin. Takada A; Sugawara Y; Takada Y Haemostasis; 1989; 19(1):26-31. PubMed ID: 2920977 [TBL] [Abstract][Full Text] [Related]
35. A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen. Madoiwa S; Arai K; Ueda Y; Ishizuka M; Mimuro J; Asakura S; Matsuda M; Sakata Y J Biochem; 1997 Feb; 121(2):278-87. PubMed ID: 9089401 [TBL] [Abstract][Full Text] [Related]
36. Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen. Takada Y; Makino Y; Takada A Thromb Res; 1985 Aug; 39(3):289-96. PubMed ID: 4049320 [TBL] [Abstract][Full Text] [Related]
37. Kinetic studies of three different molecular forms of urokinase for the activation of native human plasminogen. Toki N; Takasugi S; Sumi H Enzyme; 1981; 26(4):221-4. PubMed ID: 6788545 [TBL] [Abstract][Full Text] [Related]
38. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator. Lijnen HR; Van Hoef B; Collen D Biochim Biophys Acta; 1986 Dec; 884(3):402-8. PubMed ID: 3778931 [TBL] [Abstract][Full Text] [Related]
39. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin. Lijnen HR; Van Hoef B; Matsuo O; Collen D Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031 [TBL] [Abstract][Full Text] [Related]
40. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate. Castro MJ; Kingston IB; Anderson S Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]